Home » Instruments and Tools

Instruments and Tools

Instruments and Tools, some fundamental thoughts!

The global population is growing and needs intelligent Instruments and Tools. The approx. 8 billion people around the globe produce “things” with the help of innovation, manufacturing, trade, and the administration that other people are looking for or require, and are willing to pay a fair price for it. This creates a chain flow of money. Everyone in this chain is earning some reward, some just to survive, some a lot and some just want to run a good and secure life

We have developed a successful survival mechanism for the entire population over generations over thousands of years. However, we also must cope with competitors such as animals, bacteria, and viruses who interfere or try to control our process of life. We, humans, recognize these dangers. We learn who they are and how they work. For some people these are enemies, and they try to destroy these dangers with force. Others believe that these competitors are also part of our ecosystem and affect our well-being. They argue that we must learn to live in coexistence with them and to change our environment in such a way (innovation = change) that the competitors must look for other victims. This strategy requires research and development resulting in new technologies and behaviors. We also must focus on the production and sale of problem-solving products and therapies. With this strategy, we can create a cycle economy, intelligent progress, and a new flow of money for people.

Instruments and Tools for the life sciences

We in the life sciences can only grow through innovation. Innovation creates and needs unique instruments and tools to create unique problem solutions and methods.

Technology companies are either.

  1. Financially driven. Or
  2. Technology-driven

With a finance-oriented strategy, finance professionals (hedge funds, private equity, venture capitalists) acquire knowledge, raw materials, and companies. The prime goal is to increase the profitability and capital gains of the investments. To best returns are achieved by investing in companies. In the last few years, the hunger to earn more money has increased substantially. And so gradually the idea evolved that expanding knowledge-creating institutions/universities that are financed by tax-payers money will lead to more knowledge, innovations, and new jobs. Thus, other people argued that if more new things are created then, processes in established companies should be simplified and automated, cheaper workers to be employed, delivery times to be extended and costs reduced.  Such supply control mechanism empowers the controller to increase pricing and to earn even more money.

Greed is slowing down progress

Many have been bought by hedge funds in recent years. Then they started to buy supply companies. In a further step, these companies were consolidated. Buyers in large health and pharmaceutical companies were instructed to procure tools and raw materials from the large, controlled suppliers. This way, the diversity was reduced to low-cost commodities. Unfortunately, this is a legal form of monopoly. It is supported by leading managers, many politicians, and much of the scientific community with rational considerations and arguments.  Unfortunately, the consolidation did not result in any cost reduction! Costs e.g. for the development of a new active ingredient grew from USD 500 million (1995) to USD 4.8 billion in 2015. At the same time, knowledge produced in universities and financed with taxes was channeled into large companies.

The broad public believes that tax-funded research should improve the well-being and health of the public. However, this will only happen when new independent healthcare companies and industries emerge. Unfortunately, this is not the case. On the contrary, we are producing more qualified specialists but not enough productive jobs for these specialists. That means the state must create jobs and finance them with taxpayers’ money.

In the post-war years, there were many people with unique ideas. They decided to realize their vision with financial support from family and friends. They were driven by technology interests and they knew that effective and inexpensive products and services will be procured. It was these people who provided unique tools to the life science and health industries until around the year 2000, thus creating global growth and prosperity.

The Future path to progress.

Economists argue that real progress is only possible through competition. This means that better products displace lower quality and less developed ones. Indeed, competition leads to the continuous improvement of everything, which is particularly important in young life and health sciences.

A pharmaceutical company cannot grow unless it develops better and more competitive drugs, vaccines, diagnostics, and medical devices. Tools are an important component in this development process. In the past 10 years, the simplification of the existing processes and tools has been pushed forward. In the western world, technology-driven instrument and tool suppliers were prevented from accessing large hedge fund-controlled life science and health companies. In the past, many technologies driven companies supplied unique tools to create patent extensions by up to two years.   This meant billions in additional business income. Ignorance has eliminated this path.

Today the pharmaceutical industry is moving in all possible directions and nobody knows where the journey is going. The pharmaceutical industry is segmenting its markets into 1. Large market therapeutics, 2. therapeutics for rare(orphan) diseases and therapeutics for tropical diseases. There are around 1000 diseases in segment 1, around 7000 in segment 2, and around 25 in segment 3.

With today’s high costs it is difficult to finance the development of therapeutics for patients suffering from rare diseases. They have little chance of a cure. One day the public will discover the reality and react to it. Hedge funds should wake up and create now progress in the health and life sciences!

Fortunately, many new pharmaceuticals and other industries are evolving in Asia and emerging markets. Many emerging market governments are reluctant to partner with large finance-driven companies. They promote the local production of generic products with new financial and business models. They are also looking for instrument and tool developers who may be able to help improving productivity or to find sales partners abroad. Using new production technologies will also help to internationalize the business faster.

Creative, technology-driven Instruments and Tools Developers

Most are small private companies who put a lot of passion for continuously developing their technologies. They enjoy working with other like-minded people who have different professional skills.

In the late 1990s, we decided to work with other private companies that produce high-quality components. We saw our business in working together with creative drug discoverers and developers.  Both parties had ideas and ambitions to create together new processes that produced unique therapeutics and diagnostics. It was our job to organize the individual components from our partners and to discuss with them possibilities of productivity enhancement and creating more uniqueness and to assign ownership. Finally, we must create the final problem solution and branded it Consensus.

How can you benefit from the Consensus philosophy?

What we as partners enjoy is developing new, intelligent, and sustainable technology/instruments/devices together with all partners. It is a give and takes strategy. All those carry the risk and share the results. This way we focus on technical competency and skill to address complex customer problems and we drive the industry forward.

Consensus means

  1. In accordance (We act in accordance with international rules and regulations and with the joy of problem-solving technology from our friends and partners. Like
  2. Agreement (The various parties have reached an agreement to support each other and create high-quality products for customers.)
  3. Compliance / Compliance (All technologies/contracts have been drawn up in accordance with the same understanding of product quality or applicable law.
  4. Conformity (All components in our tools conform to definition or laws for quality or uniqueness.)
  5. Match (We will always try to reconcile all needs and ambitions between our customers, partners, and ourselves)

Every technology-driven company has expertise in one or two fields. However, to stay independent and to survive it must collaborate with a friendly partner and to sell expertise from such partners. For 25 Years we work together with many independent, highly specialized tools creating partners to create together tailored solutions under the brand name ConsensusTM XYZ. We all agree that

  • Our tools must be price competitively
  • Must be better and more advanced than mainstream competitors
  • Our approach with clients must be flexible
  • We offer quick, reliable, and competent support and service
  • As technically driven partners we communicate data, in a frank and open manner.

Our Client partners are highly skilled Chromatographers

They understand how to use and maintain their instruments and tools. In finance-driven organizations, everything must be exchangeable. Contracts are established with the equipment suppliers to maintain the Instruments. Chromatographers are tool users only. However, for us, it is important that our clients have a high degree of freedom to choose those tools so they will be sure that the instrument will improve productivity. Equipment that is cared for by its users is more cost-effective, they last longer, and the user’s job security is much better because he can react to a problem quickly. As a family owned specialist and supplier of price-competitive tools we care unable to set up in every town a sales/service office. However, the speed of solving problems is the essence of service. We are developing technologies to on-line assist our clients in every corner of the globe.  Furthermore, we guide our clients to perform easy equipment maintenance and repair. Since our beginning, we have a growing number of loyal clients. They appreciate our attention to details including quick and uncomplicated service. Thanks for your support 

Willi Glettig Proprietor